117 related articles for article (PubMed ID: 24504826)
41. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
42. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
43. Neo-adjuvant Docetaxel and Cisplatin followed by concurrent Cisplatin with radiation therapy in treatment of locally advanced nasopharyngeal carcinoma.
Hassan E; Galal K; Esmat E
Gulf J Oncolog; 2008 Jan; (3):46-53. PubMed ID: 20084797
[TBL] [Abstract][Full Text] [Related]
44. Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy.
Gao Y; Huang HQ; Bai B; Cai QC; Wang XX; Cai QQ
Expert Opin Pharmacother; 2014 Feb; 15(2):163-71. PubMed ID: 24295173
[TBL] [Abstract][Full Text] [Related]
45. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.
Lee AW; Tung SY; Ngan RK; Chappell R; Chua DT; Lu TX; Siu L; Tan T; Chan LK; Ng WT; Leung TW; Fu YT; Au GK; Zhao C; O'Sullivan B; Tan EH; Lau WH
Eur J Cancer; 2011 Mar; 47(5):656-66. PubMed ID: 21112774
[TBL] [Abstract][Full Text] [Related]
46. Concurrent chemoradiotherapy with daily low dose intra-arterial cisplatin plus 5-fluorouracil for stage IV nasopharyngeal cancer.
Kohno N; Ohno Y; Kitahara S; Tamura E; Tanabe T; Murata Y; Kawaida M
Singapore Med J; 2003 Aug; 44(8):410-3. PubMed ID: 14700420
[TBL] [Abstract][Full Text] [Related]
47. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
48. Prognostic analysis of adjuvant chemotherapy in patients with nasopharyngeal carcinoma.
Lin CC; Chen TT; Lin CY; Hsieh CY; Lin PH; Chien CR; Chiu CF; Yeh SP
Future Oncol; 2013 Oct; 9(10):1469-76. PubMed ID: 24106898
[TBL] [Abstract][Full Text] [Related]
49. [A comparison of two modalities of complex chemoradiotherapy for locally advanced nasopharyngeal carcinoma].
Alieva SB; Tkachëv SI; Matiakin EG; Kondrat'eva AP; Zimina NA; Sakharovskaia VG; Iachmeneva NF; Romanov IS
Vopr Onkol; 2004; 50(6):701-5. PubMed ID: 15755067
[TBL] [Abstract][Full Text] [Related]
50. Long-term survival of nasopharyngeal carcinoma patients treated with adjuvant chemotherapy subsequent to conventional radical radiotherapy.
Prasad U; Wahid MI; Jalaludin MA; Abdullah BJ; Paramsothy M; Abdul-Kareem S
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):648-55. PubMed ID: 12062608
[TBL] [Abstract][Full Text] [Related]
51. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
[TBL] [Abstract][Full Text] [Related]
52. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK; Hong WK; Glisson BS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):717-24. PubMed ID: 16199307
[TBL] [Abstract][Full Text] [Related]
53. Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma.
Hong S; Wu HG; Chie EK; Bang YJ; Heo DS; Kim KH; Sung MW; Park CI
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):901-5. PubMed ID: 10571196
[TBL] [Abstract][Full Text] [Related]
54. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy.
Cheng SH; Jian JJ; Tsai SY; Yen KL; Chu NM; Chan KY; Tan TD; Cheng JC; Leu SY; Hsieh CY; Huang AT
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1323-30. PubMed ID: 11121629
[TBL] [Abstract][Full Text] [Related]
55. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P
Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
[TBL] [Abstract][Full Text] [Related]
56. [Impact of changing gross tumor volume delineation of intensity-modulated radiotherapy on the dose distribution and clinical treatment outcome after induction chemotherapy for the primary locoregionally advanced nasopharyngeal carcinoma].
Yu Z; Luo W; Zhou QC; Zhang QH; Kang DH; Liu MZ
Ai Zheng; 2009 Nov; 28(11):1132-7. PubMed ID: 19895731
[TBL] [Abstract][Full Text] [Related]
57. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
[TBL] [Abstract][Full Text] [Related]
58. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
Xie FY; Zou GR; Hu WH; Qi SN; Peng M; Li JS
Ai Zheng; 2009 Mar; 28(3):279-85. PubMed ID: 19619443
[TBL] [Abstract][Full Text] [Related]
59. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
de Crevoisier R; Mazeron JJ
Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
[No Abstract] [Full Text] [Related]
60. Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer.
Bossi P; Orlandi E; Bergamini C; Locati LD; Granata R; Mirabile A; Parolini D; Franceschini M; Fallai C; Olmi P; Quattrone P; Potepan P; Gloghini A; Miceli R; Mattana F; Scaramellini G; Licitra L
Ann Oncol; 2011 Nov; 22(11):2495-2500. PubMed ID: 21398385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
